Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4092833
Max Phase: Preclinical
Molecular Formula: C32H42N5NaO10S
Molecular Weight: 689.79
Molecule Type: Small molecule
Associated Items:
ID: ALA4092833
Max Phase: Preclinical
Molecular Formula: C32H42N5NaO10S
Molecular Weight: 689.79
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCS(=O)(=O)NC[C@@H](O)[C@@H](O)[C@@H]1O[C@@](OCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)(C(=O)[O-])C[C@H](O)[C@H]1NC(C)=O.[Na+]
Standard InChI: InChI=1S/C32H43N5O10S.Na/c1-3-4-17-48(44,45)33-19-27(40)29(41)30-28(34-21(2)38)26(39)18-32(47-30,31(42)43)46-16-8-15-37-20-25(35-36-37)24-13-11-23(12-14-24)22-9-6-5-7-10-22;/h5-7,9-14,20,26-30,33,39-41H,3-4,8,15-19H2,1-2H3,(H,34,38)(H,42,43);/q;+1/p-1/t26-,27+,28+,29+,30+,32+;/m0./s1
Standard InChI Key: DMULKMJJGNAJOB-GRIGYTIASA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 689.79 | Molecular Weight (Monoisotopic): 689.2731 | AlogP: 0.90 | #Rotatable Bonds: 17 |
Polar Surface Area: 222.43 | Molecular Species: ACID | HBA: 12 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.86 | CX Basic pKa: | CX LogP: 1.35 | CX LogD: -2.14 |
Aromatic Rings: 3 | Heavy Atoms: 48 | QED Weighted: 0.11 | Np Likeness Score: -0.39 |
1. Prescher H, Frank M, Gütgemann S, Kuhfeldt E, Schweizer A, Nitschke L, Watzl C, Brossmer R.. (2017) Design, Synthesis, and Biological Evaluation of Small, High-Affinity Siglec-7 Ligands: Toward Novel Inhibitors of Cancer Immune Evasion., 60 (3): [PMID:28103033] [10.1021/acs.jmedchem.6b01111] |
Source(1):